On January 06, Curis Inc. (CRIS) announced updated data from Phase ½ Study of CA-4948 and initial clinical data from Phase 1 Study of CI-8993.
Xenetic Biosciences Inc. (XBIO) stock plunged -15.46% to $2.68 in the pre-market trading following the company’s announcement of $6.0 million registered direct offering priced at-the-market
Usio Inc. (USIO) stock soared 41.54% to $2.59 in the pre-market trading after declaring that it has entered into a non-binding Letter of Intent (LOI)
This year, biotech companies on the stock exchange have skyrocketed. This is no surprise since biotech firms are the leaders in the battle against the
Curis, Inc. (NASDAQ: CRIS), stock kicked off in pre-market session with a huge jump as it was trading 141.3% to $3.55 after a biotechnology company
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.